Fosfomycin/Tobramycin
磷霉素/妥布霉素
Report date: 2022/07/19 16:22:54
Base Information
Drug NameFosfomycin/Tobramycin
Drug Alias Name +[8]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsYes TobramycinFosfomycin sodium
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGilead Sciences Inc
China Registration ClassN/A
Develop Information
Other Information
ATC CodeN/A
Related LinksWikipedia